GALT
GALECTIN THERAPEUTICS INC
GALECTIN THERAPEUTICS INC (GALT) has 8 SEC Form 4 filings (53 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 16, 2026.
The most active filer is Chief Medical Officer Jamil Khurram with 5 filings. Insiders have net sold $522K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Joel Lewis
- Employees:15
- HQ:Norcross, GA, US
- IPO:2002-09-04
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.1M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$351.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 16,250 | $83K | Jul 16 | SEC ↗ | |
Shlevin Harold H.First in 7 months | Director | Sale | 7,732 | $39K | Jun 30 | SEC ↗ |
Shlevin Harold H.First in 7 months | Director | Sale | 22,268 | $112K | Jun 30 | SEC ↗ |
| Chief Medical Officer | Sale | 4,570 | $23K | Jun 30 | SEC ↗ | |
| Chief Medical Officer | Sale | 47,467 | $239K | Jun 30 | SEC ↗ | |
| Chief Medical Officer | Sale | 7,557 | $24K | Jun 25 | SEC ↗ | |
Jamil KhurramFirst filing | Chief Medical Officer | Sale | 568 | $2K | May 28 | SEC ↗ |
Shlevin Harold H.First filing | Insider | Sale | 139,000 | $831K | Dec 10 | SEC ↗ |
Shlevin Harold H.First filing | Insider | Sale | 16,790 | $105K | Dec 10 | SEC ↗ |
| Chief Financial Officer | Sale | 31,610 | $191K | Nov 19 | SEC ↗ | |
| Chief Financial Officer | Sale | 46,310 | $288K | Nov 19 | SEC ↗ | |
CALLICUTT JACK WFirst filing | Chief Financial Officer | Sale | 3,810 | $23K | Nov 5 | SEC ↗ |
CALLICUTT JACK WFirst filing | Chief Financial Officer | Sale | 28,629 | $174K | Nov 5 | SEC ↗ |
Related companies
GALECTIN THERAPEUTICS INC is in the Healthcare sector.